Potential for protein kinase C inhibitors in cancer therapy
- 1 January 1995
- book chapter
- Published by Springer Nature
- Vol. 78, 3-27
- https://doi.org/10.1007/978-1-4615-2007-8_1
Abstract
No abstract availableKeywords
This publication has 101 references indexed in Scilit:
- The role of protein kinase C isoenzymes in the growth inhibition caused by bryostatin 1 in human A549 lung and MCF‐7 breast carcinoma cellsInternational Journal of Cancer, 1994
- Signal transduction by lymphocyte antigen receptorsCell, 1994
- Localization of Protein Kinase C in Skeletal Muscle T-Tubule MembranesBiochemical and Biophysical Research Communications, 1993
- RO 31-8220 and RO 31-7549 show improved selectivity for protein kinase C over staurosporine in macrophagesBiochemical and Biophysical Research Communications, 1991
- Failure of wild-type or a mutant form of protein kinase C-α to transform fibroblastsNature, 1991
- Staurosporine, a potent inhibitor of C-kinase, enhances drug accumulation in multidrug-resistant cellsBiochemical and Biophysical Research Communications, 1990
- Protein kinase C-γ is present in adriamycin resistant HL-60 leukemia cellsBiochemical and Biophysical Research Communications, 1990
- Staurosporine, a potent inhibitor of phospholipidCa++dependent protein kinaseBiochemical and Biophysical Research Communications, 1986
- Bryostatin, a non-phorbol macrocyclic lactone, activates intact human polymorphonuclear leukocytes and binds to the phorbol ester receptorBiochemical and Biophysical Research Communications, 1985
- Inhibition of the calcium- and phospholipid-dependent protein kinase activity from mouse brain cytosol by quercetinBiochemical and Biophysical Research Communications, 1983